***, oxidized polymerization, and adhesion of dopamine to prepare and obtain the catechol group modified biomacromolecular scaffold material with a compound containing the catechol group.
***, a compound containing catechol groups and biomacromolecules is subjected to amidation to prepare and obtain biomacromolecules with excellent adhesion; then, the dopamine performs self-polymerization in an aqueous solution of ammonia to generate polydopamine particles which are uniform in particle size; next, a scaffold which has three cross-linking structures, namely modified biomacromolecules, modified biomacromolecules/polydopamine, and biomacromolecules/polydopamine, is formed through interaction between catechol groups, interaction between catechol groups and polydopamine particles, and interaction between macromolecules and polydopamine particles in the modified macromolecules respectively; and finally, calcium ions are cross-linked with the scaffold to obtain a gradient scaffold material.
***, hyaluronic acid, polyglutamic acid, chitosan, and polylysine.
***, hyaluronic acid or polyglutamic acid, the compound containing the catechol group is dopamine; and when biomacromolecules are chitosan or polylysine, the compound containing the catechol group is 3,4-dihydroxyphenylpropionic acid.
***-1:5, and the degree of substitution of the catechol group in the biomolecules is within the range of 16-60%.
***, the amount of ammonia water is within the range of *** mL, and the particle size of the obtained polydopamine particles is within the range of 150-560 nm.
***-pure water are 4%, and the concentration of the polydopamine particles is ***%.
***%.
***-91%.
*** *** biomacromolecules and a compound containing catechol groups to perform amidation to prepare and obtain catechol group modified biomacromolecules;freeze-drying the catechol group modified biomacromolecules to obtain a catechol group modified biomacromolecular material; or mixing the catechol group modified biomacromolecules with polydopamine, then freeze-drying the mixture of the catechol group modified biomacromolecules and polydopamine to obtain a catechol group modified biomacromolecules/polydopamine compound material; andcross-linking the freeze-dried catechol group modified biomacromolecular material or the catechol group modified biomacromolecules/polydopamine compound material by using a cross-linking agent to obtain a catechol group modified biomacromolecular compound scaffold material; or,*** biomacromolecules with polydopamine, then freeze-drying the mixture of the biomacromolecules and polydopamine to obtain a biomacromolecules/polydopamine compound material; andcross-linking the freeze-dried biomacromolecules/polydopamine compound material by using a cross-linking agent to obtain the catechol group modified biomacromolecular scaffold material.
***, hyaluronic acid, polyglutamic acid, chitosan and polylysine.
***, the cross-linking agent is calcium salt; when the biomacromolecules are hyaluronic acid or polyglutamic acid, the cross-linking agent is adipic dihydrazide;and when the biomacromolecules are chitosan or polylysine, the cross-linking agent is genipin.
***
***,4-dihydroxyphenylpropionic acid.
***, hyaluronic acid or polyglutamic acid, the compound containing the catechol groups is dopamine; and when the biomacromolecules are chitosan or polylysine, the compound containing the catechol groups is 3,4-dihydroxyphenylpropionic acid.
***-1:5.
***-60%.
***-560 nm.
***-91%.
***, being prepared and obtained with the preparation method according to claim 10.